XML 18 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Voting Common
Common Stock
Nonvoting Common
Preferred Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 29, 2018     67,435,288 1,038,413 1      
Beginning balance at Dec. 29, 2018 $ 299,951 $ 169 $ 67 $ 1 $ 0 $ 287,457 $ 12,426 $ 169
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise and vest of share-based awards (in shares)     42,438          
Exercise and vesting of share-based awards 0   $ 0     0    
Share-based compensation expense 211         211    
Dividends paid (254)           (254)  
Net income (loss) 3,774           3,774  
Comprehensive income (loss) 3,774           3,774  
Ending balance (in shares) at Mar. 30, 2019     67,477,726 1,038,413 1      
Ending balance at Mar. 30, 2019 303,851   $ 67 $ 1 $ 0 287,668 16,115  
Beginning balance (in shares) at Dec. 29, 2018     67,435,288 1,038,413 1      
Beginning balance at Dec. 29, 2018 299,951 169 $ 67 $ 1 $ 0 287,457 12,426 169
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 5,587              
Comprehensive income (loss) 5,587              
Ending balance (in shares) at Sep. 28, 2019     88,372,134 0 0      
Ending balance at Sep. 28, 2019 730,878   $ 88 $ 0 $ 0 712,987 17,803  
Beginning balance (in shares) at Mar. 30, 2019     67,477,726 1,038,413 1      
Beginning balance at Mar. 30, 2019 303,851   $ 67 $ 1 $ 0 287,668 16,115  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise and vest of share-based awards (in shares)       30,000        
Exercise and vesting of share-based awards 314         314    
Issuance of common stock upon initial public offering, net of issuance costs (in shares)     19,765,625          
Issuance of common stock upon initial public offering, net of issuance costs 400,488   $ 20     400,468    
Conversion of nonvoting to voting common shares (in shares)     1,068,413 (1,068,413)        
Conversion of nonvoting to voting common shares 0   $ 1 $ (1)        
Redemption of preferred shares (in shares)         (1)      
Share-based compensation expense 22,750         22,750    
Dividends paid (83)           (83)  
Net income (loss) (10,632)           (10,632)  
Comprehensive income (loss) (10,632)           (10,632)  
Ending balance (in shares) at Jun. 29, 2019     88,311,764 0 0      
Ending balance at Jun. 29, 2019 716,688   $ 88 $ 0 $ 0 711,200 5,400  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise and vest of share-based awards (in shares)     60,370          
Exercise and vesting of share-based awards (1,021)   $ 0     (1,021)    
Deferred offering costs (84)         (84)    
Share-based compensation expense 2,892         2,892    
Dividends paid (42)           (42)  
Net income (loss) 12,445           12,445  
Comprehensive income (loss) 12,445           12,445  
Ending balance (in shares) at Sep. 28, 2019     88,372,134 0 0      
Ending balance at Sep. 28, 2019 730,878   $ 88 $ 0 $ 0 712,987 17,803  
Beginning balance (in shares) at Dec. 28, 2019     89,005,062 0 0      
Beginning balance at Dec. 28, 2019 745,384 439 $ 89 $ 0 $ 0 717,282 28,013 439
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise and vest of share-based awards (in shares)     902,132          
Exercise and vesting of share-based awards 6,033   $ 1     6,032    
Share-based compensation expense 20,277         20,277    
Dividends paid (147)         (147)    
Net income (loss) 12,642           12,642  
Comprehensive income (loss) 12,642           12,642  
Ending balance (in shares) at Mar. 28, 2020     89,907,194 0 0      
Ending balance at Mar. 28, 2020 784,628   $ 90 $ 0 $ 0 743,444 41,094  
Beginning balance (in shares) at Dec. 28, 2019     89,005,062 0 0      
Beginning balance at Dec. 28, 2019 745,384 $ 439 $ 89 $ 0 $ 0 717,282 28,013 $ 439
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 82,449              
Comprehensive income (loss) 82,449              
Ending balance (in shares) at Sep. 26, 2020     93,904,922 0 0      
Ending balance at Sep. 26, 2020 888,826   $ 94 $ 0 $ 0 777,831 110,901  
Beginning balance (in shares) at Mar. 28, 2020     89,907,194 0 0      
Beginning balance at Mar. 28, 2020 784,628   $ 90 $ 0 $ 0 743,444 41,094  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise and vest of share-based awards (in shares)     1,511,079          
Exercise and vesting of share-based awards 9,845   $ 1     9,844    
Tax paid on behalf of employees related to net settlement of share-based awards (483)         (483)    
Share-based compensation expense 10,175         10,175    
Dividends paid (97)         (97)    
Net income (loss) 29,333           29,333  
Comprehensive income (loss) 29,333           29,333  
Ending balance (in shares) at Jun. 27, 2020     91,418,273 0 0      
Ending balance at Jun. 27, 2020 833,401   $ 91 $ 0 $ 0 762,883 70,427  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise and vest of share-based awards (in shares)     2,486,649          
Exercise and vesting of share-based awards 11,255   $ 3     11,252    
Share-based compensation expense 3,857         3,857    
Dividends paid (161)         (161)    
Net income (loss) 40,474           40,474  
Comprehensive income (loss) 40,474           40,474  
Ending balance (in shares) at Sep. 26, 2020     93,904,922 0 0      
Ending balance at Sep. 26, 2020 $ 888,826   $ 94 $ 0 $ 0 $ 777,831 $ 110,901